QQ客服 官方微博 反馈留言

浏览/检索结果: 共17条，第1-10条 帮助 限定条件 发表日期：2020     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Determination of the antidiabetic chemical basis of Phellodendri Chinensis Cortex by integrating hepatic disposition in vivo and hepatic gluconeogenese inhibition in vitro 期刊论文 JOURNAL OF ETHNOPHARMACOLOGY, 2020, 卷号: 263, 页码: 10 作者:  Tian, Xiaoting;  Xu, Zhou;  Hu, Pei;  Yu, Yanyan;  Li, Zhixiong 收藏  |  浏览/下载：74/0  |  提交时间：2020/12/21 Phellodendri Chinensis cortex  Hepatic disposition  Pharmacokinetics  Berberine  Metabolites  Hepatic gluconeogenesis   Pharmacokinetics, mass balance, and metabolism of [C-14]vicagrel, a novel irreversible P2Y(12) inhibitor in humans 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Zheng, Yuan-dong;  Zhang, Hua;  Zhan, Yan;  Bian, Yi-cong;  Ma, Sheng 收藏  |  浏览/下载：44/0  |  提交时间：2021/05/24 vicagrel  [C-14]vicagrel  vicagrel pharmacokinetics  vicagrel metabolism  mass balance  P2Y(12) receptor inhibitor   Efficient delivery of clay-based nanovaccines to the mouse spleen promotes potent anti-tumor immunity for both prevention and treatment of lymphoma 期刊论文 NANO RESEARCH, 2020, 页码: 9 作者:  Zhang, Ling-Xiao;  Jia, Ying-Bo;  Huang, Ya-Ru;  Liu, Hui-Na;  Sun, Xia-Mei 收藏  |  浏览/下载：15/0  |  提交时间：2021/03/29 cancer immunotherapy  nanovaccine  layered double hydroxide  targeted delivery to the spleen  lymphoma   Drug interaction of ningetinib and gefitinib involving CYP1A1 and efflux transporters in non-small cell lung cancer patients 期刊论文 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 页码: 13 作者:  Liu, Lu;  Wang, Qian;  Xie, Cen;  Xi, Ning;  Guo, Zitao 收藏  |  浏览/下载：55/0  |  提交时间：2020/12/24 drug–  drug interaction  gefitinib  ningetinib  transporters   Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors 期刊论文 BIOCHEMICAL PHARMACOLOGY, 2020, 卷号: 180, 页码: 16 作者:  Darbalaei, Sanaz;  Yuliantie, Elita;  Dai, Antao;  Chang, Rulue;  Zhao, Peishen 收藏  |  浏览/下载：19/0  |  提交时间：2020/12/21 G protein-coupled receptor  Glucagon-like peptide-1 receptor  Glucagon receptor  Biased agonism  Unimolecular dual agonist   Repurposing of Kinase Inhibitors for Treatment of COVID-19 期刊论文 PHARMACEUTICAL RESEARCH, 2020, 卷号: 37 作者:  Weisberg, Ellen;  Parent, Alexander;  Yang, Priscilla L.;  Sattler, Martin;  Liu, Qingsong 收藏  |  浏览/下载：34/0  |  提交时间：2020/10/26 Coronavirus  SARS-CoV-2  SARS-CoV  MERS-CoV  kinase inhibitors  pharmacokinetics  antiviral therapy  COVID-19   Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9 作者:  Tian, Qian-qian;  Zhu, Yun-ting;  Diao, Xing-xing;  Zhang, Xiang-lei;  Xu, Ye-chun 收藏  |  浏览/下载：68/0  |  提交时间：2020/12/24 PDE5 inhibitor  TPN729  M3  species difference  pharmacokinetics  metabolite identification   Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026 作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong 收藏  |  浏览/下载：38/0  |  提交时间：2020/12/24 Alflutinib  NSCLC  EGFR T790M mutation  Efficacy  Safety   Qualitative and quantitative determination of anaprazole and its major metabolites in human plasma 期刊论文 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 卷号: 183, 页码: 10 作者:  Tang, Chongzhuang;  Li, Liang;  Ma, Xifeng;  Wang, Jin;  Chen, Bo 收藏  |  浏览/下载：82/0  |  提交时间：2020/07/01 Metabolite identification  LC-MS/MS  UPLC-UV/Q-TOF  Anaprazole   An UHPLC-TOF-MS method for quantifying novel brominated anticancer compound bromophenol-thiosemicarbazone hybrid and its application to in vivo pharmacokinetic study 期刊论文 JOURNAL OF ANALYTICAL SCIENCE AND TECHNOLOGY, 2020, 卷号: 11, 期号: 1, 页码: 7 作者:  Li, Xiuxue;  Wang, Lijun;  Jia, Xiaoling;  Guo, Chuanlong;  Li, Chao 收藏  |  浏览/下载：21/0  |  提交时间：2020/09/23 Novel compound  Quantitation  UHPLC-TOF-MS  Pharmacokinetics